Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Hsin Lee

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
RSC Chemical Biology|February 2, 2026
Signatures of native-like glycosylation in RNA replicon-derived HIV-1 immunogensHimanshi Chawla, Jacob T Willcox, Grace M Hayes, et al.
Elife|August 11, 2018
Structure of the human volume regulated anion channelJennifer M Kefauver, Kei Saotome, Adrienne E Dubin, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.
The Journal of Biological Chemistry|February 8, 2019
Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimersSteven W de Taeye, Eden P Go, Kwinten Sliepen, et al.
Plos Pathogens|June 10, 2024
The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccineXiaorui Chen, Arpita Mohapatra, Hong Thuy Vy Nguyen, et al.
The Journal of Experimental Medicine|March 4, 2015
Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokinesHeng-Hsiung Wu, Wendy W Hwang-Verslues, Wen-Hsin Lee, et al.
Journal of Pharmaceutical Sciences|February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine AntigensNeal Whitaker, John M Hickey, Kawaljit Kaur, et al.
Cell Reports|March 2, 2022
Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodiesAnusmita Sahoo, Edgar A Hodge, Celia C LaBranche, et al.
Cell Reports|March 30, 2025
Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelopeMichael V Bick, Eduard Puig, David Beauparlant, et al.
Cell Reports|September 7, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
RSC Chemical Biology|February 2, 2026
Signatures of native-like glycosylation in RNA replicon-derived HIV-1 immunogensHimanshi Chawla, Jacob T Willcox, Grace M Hayes, et al.
Elife|August 11, 2018
Structure of the human volume regulated anion channelJennifer M Kefauver, Kei Saotome, Adrienne E Dubin, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.
The Journal of Biological Chemistry|February 8, 2019
Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimersSteven W de Taeye, Eden P Go, Kwinten Sliepen, et al.
Plos Pathogens|June 10, 2024
The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccineXiaorui Chen, Arpita Mohapatra, Hong Thuy Vy Nguyen, et al.
The Journal of Experimental Medicine|March 4, 2015
Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokinesHeng-Hsiung Wu, Wendy W Hwang-Verslues, Wen-Hsin Lee, et al.
Journal of Pharmaceutical Sciences|February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine AntigensNeal Whitaker, John M Hickey, Kawaljit Kaur, et al.
Cell Reports|March 2, 2022
Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodiesAnusmita Sahoo, Edgar A Hodge, Celia C LaBranche, et al.
Cell Reports|March 30, 2025
Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelopeMichael V Bick, Eduard Puig, David Beauparlant, et al.
Cell Reports|September 7, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.
Pageof 8